Obalon Wins 2 US Patents For Intragastric Balloon System


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Shares of micro-cap Obalon Therapeutics Inc (NASDAQ:OBLN) traded higher Tuesday after the company announced it has obtained two new U.S. patents covering its proprietary intragastric balloon system.

The Obalon balloon system is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.

Obalon Therapeutics shares were trading higher by 4.27% at 64 cents at the time of publication Tuesday. 

Related Links:

Obalon Ticks Higher Amid Patent Abstract For Intragastric Device

Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsPenny StocksMarketsGeneral